复发性血栓性静脉炎患者遗传性异常抗凝血酶III组分的纯化及部分特性分析 - Suppr

Suppr

超能文献

Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis.

作者信息

Tran T H, Bounameaux H, Bondeli C, Honkanen H, Marbet G A, Duckert F

出版信息

Thromb Haemost. 1980 Oct 31;44(2):87-91.

PMID:7455996

Abstract

摘要

相似文献

Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis.

Thromb Haemost. 1980 Oct 31;44(2):87-91.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

J Lab Clin Med. 1984 Aug;104(2):245-56.

Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.

Thromb Res. 1983 Jul 15;31(2):319-28. doi: 10.1016/0049-3848(83)90334-1.

A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.

Thromb Res. 1985 Sep 1;39(5):559-70. doi: 10.1016/0049-3848(85)90236-1.

[Hereditary abnormalities of antithrombin III in patients with recurrent thrombophlebitis].

Med Arh. 1986;40(1-2):51-3.

Antithrombin III Toyama: a congenital antithrombin III abnormality with recurrent thrombophlebitis.

Nihon Ketsueki Gakkai Zasshi. 1985 Dec;48(8):1895-905.

Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.

Thromb Res. 1983 Jul 15;31(2):305-17. doi: 10.1016/0049-3848(83)90333-x.

Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').

Ric Clin Lab. 1984 Jul-Sep;14(3):515-9. doi: 10.1007/BF02904879.

[Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].

Pol Tyg Lek. 1985 Oct 28;40(43):1202-4.

Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.

Acta Biochim Pol. 1982;29(1-2):95-103.

引用本文的文献

Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Blut. 1983 Aug;47(2):93-103. doi: 10.1007/BF02482643.

Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Proc Natl Acad Sci U S A. 1984 Jan;81(2):289-93. doi: 10.1073/pnas.81.2.289.

Isolation and sequence characterization of a cDNA clone of human antithrombin III.

Proc Natl Acad Sci U S A. 1983 Apr;80(7):1845-8. doi: 10.1073/pnas.80.7.1845.

Familial venous thrombosis.

Postgrad Med J. 1983 Nov;59(697):677-89. doi: 10.1136/pgmj.59.697.677.

Genetic mapping of the structural gene for antithrombin III to human chromosome 1.

Hum Genet. 1984;67(1):34-6. doi: 10.1007/BF00270555.

Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.

J Clin Invest. 1985 Jan;75(1):272-9. doi: 10.1172/JCI111685.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验